34.86 USD
-0.7 (-1.97%)
34.86 USD
0 (0%)
Taking everything into account, AZTA scores 4 out of 10 in our fundamental rating. AZTA was compared to 58 industry peers in the Life Sciences Tools & Services industry. While AZTA has a great health rating, there are worries on its profitability. AZTA has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
AZTA had positive earnings in the past year.
In the past year AZTA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AZTA reported negative net income in multiple years.
In multiple years AZTA reported negative operating cash flow during the last 5 years.
1.2 Ratios
AZTA has a Return On Assets of -5.53%. This is comparable to the rest of the industry: AZTA outperforms 55.17% of its industry peers.
With a Return On Equity value of -6.67%, AZTA perfoms like the industry average, outperforming 56.90% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.53% | ||
| ROE | -6.67% | ||
| ROIC | N/A |
ROA(3y)16.36%
ROA(5y)11.87%
ROE(3y)17.86%
ROE(5y)13.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 44.92%, AZTA perfoms like the industry average, outperforming 44.83% of the companies in the same industry.
In the last couple of years the Gross Margin of AZTA has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AZTA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.44%
GM growth 5Y-0.19%
2. Health
2.1 Basic Checks
AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 4.28 indicates that AZTA is not in any danger for bankruptcy at the moment.
The Altman-Z score of AZTA (4.28) is better than 72.41% of its industry peers.
There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 4.28 |
ROIC/WACCN/A
WACC10.15%
2.3 Liquidity
AZTA has a Current Ratio of 2.76. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
AZTA's Current ratio of 2.76 is in line compared to the rest of the industry. AZTA outperforms 50.00% of its industry peers.
AZTA has a Quick Ratio of 2.44. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
AZTA has a Quick ratio (2.44) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.76 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 29.27% over the past year.
AZTA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -16.04% yearly.
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.39%
3.2 Future
The Earnings Per Share is expected to grow by 27.49% on average over the next years. This is a very strong growth
AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y48.94%
EPS Next 2Y36.17%
EPS Next 3Y36.28%
EPS Next 5Y27.49%
Revenue Next Year4.15%
Revenue Next 2Y4.27%
Revenue Next 3Y5.4%
Revenue Next 5Y5.37%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AZTA is valuated quite expensively with a Price/Earnings ratio of 65.77.
AZTA's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of AZTA to the average of the S&P500 Index (26.31), we can say AZTA is valued expensively.
The Price/Forward Earnings ratio is 44.16, which means the current valuation is very expensive for AZTA.
AZTA's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.56, AZTA is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.77 | ||
| Fwd PE | 44.16 |
4.2 Price Multiples
60.34% of the companies in the same industry are more expensive than AZTA, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, AZTA is valued a bit cheaper than 70.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.99 | ||
| EV/EBITDA | 34.92 |
4.3 Compensation for Growth
AZTA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as AZTA's earnings are expected to grow with 36.28% in the coming years.
PEG (NY)1.34
PEG (5Y)N/A
EPS Next 2Y36.17%
EPS Next 3Y36.28%
5. Dividend
5.1 Amount
No dividends for AZTA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.86
-0.7 (-1.97%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners116.57%
Inst Owner ChangeN/A
Ins Owners0.63%
Ins Owner Change11.29%
Market Cap1.60B
Revenue(TTM)N/A
Net Income(TTM)-111.59M
Analysts74.29
Price Target33.95 (-2.61%)
Short Float %6.9%
Short Ratio5.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.12%
Min EPS beat(2)-29.97%
Max EPS beat(2)36.22%
EPS beat(4)3
Avg EPS beat(4)28.83%
Min EPS beat(4)-29.97%
Max EPS beat(4)71.81%
EPS beat(8)7
Avg EPS beat(8)146.76%
EPS beat(12)10
Avg EPS beat(12)157.49%
EPS beat(16)13
Avg EPS beat(16)123.07%
Revenue beat(2)0
Avg Revenue beat(2)-2.89%
Min Revenue beat(2)-5.56%
Max Revenue beat(2)-0.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.14%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.22%
Revenue beat(8)3
Avg Revenue beat(8)-0.72%
Revenue beat(12)5
Avg Revenue beat(12)-1.03%
Revenue beat(16)7
Avg Revenue beat(16)-4.7%
PT rev (1m)5.91%
PT rev (3m)5.91%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-1.74%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-0.55%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 65.77 | ||
| Fwd PE | 44.16 | ||
| P/S | 2.64 | ||
| P/FCF | 34.99 | ||
| P/OCF | 19.09 | ||
| P/B | 0.95 | ||
| P/tB | 1.85 | ||
| EV/EBITDA | 34.92 |
EPS(TTM)0.53
EY1.52%
EPS(NY)0.79
Fwd EY2.26%
FCF(TTM)1
FCFY2.86%
OCF(TTM)1.83
OCFY5.24%
SpS13.2
BVpS36.51
TBVpS18.8
PEG (NY)1.34
PEG (5Y)N/A
Graham Number20.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.53% | ||
| ROE | -6.67% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.92% | ||
| FCFM | 7.55% |
ROA(3y)16.36%
ROA(5y)11.87%
ROE(3y)17.86%
ROE(5y)13.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.44%
GM growth 5Y-0.19%
F-Score7
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 53.88% | ||
| Cap/Sales | 6.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 231.56% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.76 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 4.28 |
F-Score7
WACC10.15%
ROIC/WACCN/A
Cap/Depr(3y)77.14%
Cap/Depr(5y)74.64%
Cap/Sales(3y)8.52%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.27%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%16.67%
EPS Next Y48.94%
EPS Next 2Y36.17%
EPS Next 3Y36.28%
EPS Next 5Y27.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-6.39%
Revenue Next Year4.15%
Revenue Next 2Y4.27%
Revenue Next 3Y5.4%
Revenue Next 5Y5.37%
EBIT growth 1Y55.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1010.56%
EBIT Next 3Y149.86%
EBIT Next 5Y107.99%
FCF growth 1Y182.14%
FCF growth 3Y-48.98%
FCF growth 5Y-28.07%
OCF growth 1Y759.23%
OCF growth 3Y-30.52%
OCF growth 5Y-11.17%
AZENTA INC / AZTA FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 4 / 10 to AZTA.
Can you provide the valuation status for AZENTA INC?
ChartMill assigns a valuation rating of 4 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.
How profitable is AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a profitability rating of 2 / 10.
What is the financial health of AZENTA INC (AZTA) stock?
The financial health rating of AZENTA INC (AZTA) is 7 / 10.
Is the dividend of AZENTA INC sustainable?
The dividend rating of AZENTA INC (AZTA) is 0 / 10 and the dividend payout ratio is 0%.